Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer
Authors
Keywords
Sarcopenia, Skeletal muscle mass, Lean body mass, Head and neck neoplasms, Radiochemotherapy, Chemotherapy dose-limiting toxicity, Computer-assisted image analysis
Journal
ORAL ONCOLOGY
Volume 71, Issue -, Pages 26-33
Publisher
Elsevier BV
Online
2017-06-05
DOI
10.1016/j.oraloncology.2017.05.012

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.